Health X Platform Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book
Published 26 Aug 2026 | Healthcare Services | Market Cap: ₹977 Cr
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Health X aims to convert strong revenue growth into sustainable EBITDA and PAT profitability through operating leverage and tighter cost management.
From Health X Platform Ltd's Q1 FY27 earnings-call transcript · updated 26 Aug 2026.
Price
₹298
Market Cap
₹977 Cr
P/E Ratio
508.6
Revenue Rank
Margin Rank
How does Health X Platform Ltd rank in Healthcare Services?
Compare Health X Platform Ltd against every Healthcare Services company this quarter on revenue, margins and earnings-call signals.
Health X Platform Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹346 Cr, net profit ₹0 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 1- →July monthly revenue stood at INR 150+ crores, indicating strong growth momentum.
- →Expansion into new regions including Odisha, Jharkhand, Bihar, Chhattisgarh, Haryana, UP, Rajasthan, and Northeast India; Northeast shows highest growth.
- →Target to double market share in West Bengal from current 3-4% to about 7% over next 2-3 years.
- →Growing JITO private label sales rapidly (from INR 25 lakhs to INR 79 lakhs recently), expected to significantly contribute to revenue and gross margin expansion.
- →RetailerShakti business focusing on increasing wallet share per retailer, aiming to double it through AI-enabled Retail Air platform launching next quarter.
- →Ongoing build-out of warehouses in key geographies to support increased capacity and faster delivery.
- →Company anticipates FY27 to be best year in history with continued strong scaling of both RetailerShakti and SastaSundar.
- →Gradual ramp-up of JITO and geographic expansion expected to drive sustainable sales growth.
📈 Profitability & Margins
Rank 1- →Health X aims to convert strong revenue growth into sustainable EBITDA and PAT profitability through operating leverage and tighter cost management.
- →RetailerShakti expects positive EBITDA by Q3 FY27, currently close to break even with a gross margin around 7.8%.
- →SastaSundar is focused on building scale rather than near-term EBITDA positivity; EBITDA losses largely due to tech investments.
- →The company targets maintaining gross margins around 8% to 12% industry levels over time.
- →Revenue growth driven by geographical expansion, fulfilment infrastructure, and scaling of private label JITO products with high gross margins (~50%).
- →PAT improved to INR 2 crores in Q1 FY27 from a loss last quarter, indicating progress toward profitability.
- →Management does not provide explicit EPS guidance but emphasizes capital efficiency and sustainable cash flow growth over EBITDA in the short to medium term.
🏗️ Capital Expenditure Plans
Yes- →Health X is focused on owning its entire logistics and fulfillment centers instead of relying on outside warehouses, making it a USP.
- →Existing fulfillment center capacity is running at about 90%, with an "existing plus" sideway extension planned to cover 50%-100% more revenue growth, supporting up to INR 3,000 crores revenue.
- →Beyond this, massive infrastructure development is planned to build seamless large-scale capabilities.
- →New warehouse capabilities are under construction in multiple locations: Noida (completed), West Bengal (partly done), Guwahati (under construction), Udaipur (started), and planned starts in Patna and Lucknow within 2-3 months.
- →Capex plans include shifting from rented warehouses to owned facilities, prioritizing Guwahati.
- →Investments are ongoing in technology, including AI-enabled tools for retailers and customers, with a commitment to continue tech investments even if it means ongoing burn.
- →The approach favors capital efficiency by building assets organically rather than acquiring at a premium.
💰 Fundraising & Capital Structure
No information- →No explicit mention of any current or immediate new fundraising through debt or equity in the provided transcript.
- →The company is focused on capital efficiency, having built capital base through treasury income and avoiding dilution by not acquiring revenue.
- →They emphasize building infrastructure and technology primarily through internal resources and capex plans rather than external fundraises.
- →Mention of a capex plan to build new warehouse capabilities as part of future infrastructure growth, but no details on fundraising for this.
- →The company is on track with regulatory approvals (SEBI) related to merger/demerger, but no indication of fundraising linked to this.
- →Management indicates continued investment (burn) in technology and growth funded internally for the near future.
📋 Order Book & Pipeline
YesKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were Health X Platform Ltd Q1 FY27 results?
July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Health X aims to convert strong revenue growth into sustainable EBITDA and PAT profitability through operating leverage and tighter cost management.
What is Health X Platform Ltd share price analysis?
Health X Platform Ltd currently shows a strong growth signal based on ranking data. The stock trades at a P/E of 508.6 with a market cap of ₹977 Cr. Investors should review the full earnings analysis for detailed insights.
Is Health X Platform Ltd planning capital expenditure?
Health X is focused on owning its entire logistics and fulfillment centers instead of relying on outside warehouses, making it a USP.
Keep Health X Platform Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.